Xtant Medical Holdings, Inc. (XTNT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 15M 30M 45M Q3 '21: 13.8M Q4 '21: 14M Q1 '22: 13M Q2 '22: 15.3M Q3 '22: 14.5M Q4 '22: 15.3M Q1 '23: 17.9M Q2 '23: 20.2M Q3 '23: 25M Q4 '23: 28.1M Q1 '24: 27.9M Q2 '24: 29.9M Q3 '24: 27.9M Q4 '24: 31.5M Q1 '25: 32.9M Q2 '25: 35.4M Q3 '25: 33.3M Q4 '25: 32.4M Q1 '26: 20.9M Q2 '26: 23M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 9M 18M 27M Q3 '21: 7.2M Q4 '21: 7.7M Q1 '22: 7.6M Q2 '22: 8.4M Q3 '22: 7.9M Q4 '22: 8.3M Q1 '23: 10.5M Q2 '23: 12.5M Q3 '23: 15.3M Q4 '23: 17.1M Q1 '24: 17.3M Q2 '24: 18.6M Q3 '24: 16.3M Q4 '24: 16M Q1 '25: 20.2M Q2 '25: 24.3M Q3 '25: 22M Q4 '25: 17.8M Q1 '26: 12M Q2 '26: 13.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q2 '21: -491K Q3 '21: -1.4M Q4 '21: -1.9M Q1 '22: -1.8M Q2 '22: -1.3M Q3 '22: -1.9M Q4 '22: -1.7M Q1 '23: -1.6M Q2 '23: -1.4M Q3 '23: -3.4M Q4 '23: -3.8M Q1 '24: -3.5M Q2 '24: -2.9M Q3 '24: -3.8M Q4 '24: -1.9M Q1 '25: 1.1M Q2 '25: 4.6M Q3 '25: 2.5M Q1 '26: -2.9M Q2 '26: -9.2M Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q2 '26

Net Income Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q3 '21: -1.8M Q4 '21: -2.3M Q1 '22: -2.2M Q2 '22: -1.7M Q3 '22: -2.4M Q4 '22: -2.2M Q1 '23: -2.1M Q2 '23: -2.2M Q3 '23: 9.2M Q4 '23: -4.3M Q1 '24: -4.4M Q2 '24: -3.9M Q3 '24: -5M Q4 '24: -3.2M Q1 '25: 58K Q2 '25: 3.5M Q3 '25: 1.3M Q4 '25: 57K Q1 '26: -3.1M Q2 '26: -9.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 6M 12M 18M Q3 '21: 6.6M Q4 '21: 6.3M Q1 '22: 5.4M Q2 '22: 6.9M Q3 '22: 6.6M Q4 '22: 7M Q1 '23: 7.4M Q2 '23: 7.8M Q3 '23: 9.7M Q4 '23: 11M Q1 '24: 10.6M Q2 '24: 11.4M Q3 '24: 11.6M Q4 '24: 15.5M Q1 '25: 12.7M Q2 '25: 11.1M Q3 '25: 11.3M Q4 '25: 14.6M Q1 '26: 8.9M Q2 '26: 9.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q3 '21: -926K Q4 '21: 423K Q1 '22: -1M Q2 '22: 15K Q3 '22: -2.1M Q4 '22: -2.3M Q1 '23: -2.2M Q2 '23: -2.5M Q3 '23: -3.8M Q4 '23: -915K Q1 '24: -5.8M Q2 '24: -5.1M Q3 '24: -1.7M Q4 '24: 665K Q1 '25: 1.3M Q2 '25: 1.3M Q3 '25: 4.6M Q4 '25: 5.4M Q1 '26: -2.1M Q2 '26: -7.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-9M -6M -3M 0 3M 6M 9M Q3 '21: -1.3M Q4 '21: -203K Q1 '22: -1.5M Q2 '22: -311K Q3 '22: -2.6M Q4 '22: -2.7M Q1 '23: -2.7M Q2 '23: -2.9M Q3 '23: -4.1M Q4 '23: -1.3M Q1 '24: -6.5M Q2 '24: -5.7M Q3 '24: -3.8M Q4 '24: -7K Q1 '25: 87K Q2 '25: 910K Q3 '25: 4.2M Q4 '25: 5M Q1 '26: -2.3M Q2 '26: -7.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 60M 120M 180M Q1 '20: 13.2M Q2 '20: 13.2M Q3 '20: 13.2M Q1 '21: 81.2M Q2 '21: 86.7M Q3 '21: 86.8M Q1 '22: 87.2M Q2 '22: 87.3M Q3 '22: 93.3M Q1 '23: 108.9M Q2 '23: 108.9M Q3 '23: 135.7M Q1 '24: 130.2M Q2 '24: 130.3M Q3 '24: 135.1M Q1 '25: 143.3M Q2 '25: 148.6M Q3 '25: 150.4M Q1 '26: 140.1M Q2 '26: 140.3M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.14 -0.07 0.00 0.07 0.14 0.21 Q3 '21: 0.20 Q4 '21: -0.06 Q1 '22: -0.09 Q2 '22: -0.10 Q3 '22: -0.11 Q4 '22: -0.10 Q1 '23: -0.09 Q2 '23: -0.09 Q3 '23: 0.01 Q4 '23: 0.01 Q1 '24: 0.00 Q2 '24: -0.01 Q3 '24: -0.12 Q4 '24: -0.12 Q1 '25: -0.09 Q2 '25: -0.04 Q3 '25: 0.01 Q4 '25: 0.03 Q1 '26: 0.01 Q2 '26: -0.08 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.